Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Earnings

ACM Research Shares Plunge on Disappointing Earnings Report

Felix Baarz by Felix Baarz
November 10, 2025
in Earnings, Semiconductors, TecDAX
0
ACM Research Stock
0
SHARES
16
VIEWS
Share on FacebookShare on Twitter

Investors in semiconductor equipment maker ACM Research were met with an unpleasant surprise following the company’s latest quarterly results. While the firm demonstrated impressive revenue growth, underlying profitability metrics and a revised outlook sent shares tumbling nearly 20% in a single trading session on November 5th. The dramatic sell-off raises questions about the company’s near-term trajectory amid a challenging industry backdrop.

Profitability and Guidance Concerns Overshadow Revenue Beat

The third-quarter report presented a conflicting picture. ACM Research posted revenue of $269.16 million, a robust 32% year-over-year increase that comfortably surpassed analyst projections. However, this strong top-line performance masked significant weakness beneath the surface.

The company’s profitability came under intense scrutiny. Adjusted earnings per share landed at just $0.36, falling substantially short of the $0.47 to $0.55 range anticipated by market experts. More alarming was the severe compression in gross margin, which contracted from 51.6% to 42.1%. This places the metric at the lower boundary of the company’s long-term target range and indicates mounting cost pressures.

Management’s Cautious Stance Weighs on Sentiment

Perhaps the most damaging element for investor confidence was management’s decision to scale back its full-year forecast. The company now anticipates 2025 revenue between $875 million and $925 million. Although the midpoint of this range still represents a respectable 15% growth rate, it falls below the analyst consensus estimate of $914.6 million.

Should investors sell immediately? Or is it worth buying ACM Research?

CEO Dr. David Wang highlighted continued progress with key product lines, including single-wafer processing systems and advanced plating solutions. Nevertheless, the conservative guidance suggests that industry headwinds—including trade tensions, uncertain customer spending patterns, and persistent supply chain constraints—are impacting the business outlook more significantly than previously anticipated.

Technical and Insider Selling Patterns Signal Trouble

The negative fundamental developments were compounded by concerning technical and behavioral indicators. ACM Research shares have declined in six of the past ten trading sessions, plummeting more than 22% over the past week alone. The stock now trades more than 25% below its 52-week high.

Adding to the bearish sentiment, corporate insiders have been reducing their positions in recent months. Several key executives have sold substantial shareholdings in the open market. When viewed alongside the weak earnings performance and cautious guidance, these insider transactions point to sustained downward pressure.

While ACM Research maintains an ambitious long-term vision targeting $4 billion in annual revenue, the current quarterly results demonstrate that achieving this goal may prove more challenging than many investors had hoped. The path forward appears increasingly difficult as the company navigates both internal profitability issues and external market pressures.

Ad

ACM Research Stock: Buy or Sell?! New ACM Research Analysis from March 25 delivers the answer:

The latest ACM Research figures speak for themselves: Urgent action needed for ACM Research investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

ACM Research: Buy or sell? Read more here...

Tags: ACM Research
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026
Humacyte Stock
Analysis

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Talphera Stock
Analysis

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026
Next Post
Yum China Stock

Yum China Shares Show Signs of Recovery Momentum

Broadcom Stock

Broadcom Shares: A Tale of Two Trading Strategies

Unity Software Stock

Unity Software Shares Surge Following Strong Quarterly Results and Analyst Upgrade

Recommended

Alphabet Stock

Alphabet Shares Face Regulatory Headwinds Despite Autonomous Driving Breakthrough

4 months ago
Dish Network Stock

Institutional Investors Show Diverging Views on Dish Network’s Future

7 months ago
Finance_ Trading ratings today (2)

Lakeland Financial Exceeds Expectations with Fourth Quarter Earnings

2 years ago
DeFi Technologies Stock

DeFi Technologies: Navigating Expansion Amidst Legal Headwinds

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

Trending

BioNano Genomics Stock
Analysis

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

by Kennethcix
March 25, 2026
0

BioNano Genomics has wrapped up its fiscal year 2025, presenting a financial picture marked by significant operational...

Humacyte Stock

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026
Evolent Health Stock

Evolent Health Bets on AI Leadership Amid Share Price Decline

March 25, 2026
MongoDB Stock

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Talphera Stock

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds
  • Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts
  • Evolent Health Bets on AI Leadership Amid Share Price Decline

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com